The Functional Crosstalk between HER2 Tyrosine Kinase and TGF-β Signaling in Breast Cancer Malignancy
2011
The Interaction Between HER2 and TGF-β in Breast Cancer
publication
Evidence: moderate
Author Information
Author(s): Shizhen Emily Wang
Primary Institution: Beckman Research Institute of City of Hope
Hypothesis
How does the crosstalk between HER2 and TGF-β influence breast cancer progression and treatment resistance?
Conclusion
The study suggests that the interaction between HER2 and TGF-β promotes breast cancer malignancy and resistance to therapies.
Supporting Evidence
- TGF-β can change from a tumor suppressor to a promoter of cancer when HER2 is overexpressed.
- HER2 overexpression is linked to increased cancer cell survival and resistance to treatments.
- Blocking the interaction between HER2 and TGF-β may improve treatment outcomes for breast cancer patients.
Takeaway
HER2 and TGF-β work together in breast cancer to help the cancer grow and resist treatments, making it harder to treat.
Methodology
The study utilized cell culture models to investigate the effects of HER2 overexpression and TGF-β signaling.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website